Search Results - "A. Pessino"

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings by Cavaletti, G., Cornblath, D.R., Merkies, I.S.J., Postma, T.J., Rossi, E., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A.A., Kalofonos, H.P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Dalla Torre, C., Faber, C.G., Lalisang, R.I., Boogerd, W., Brandsma, D., Koeppen, S., Hense, J., Storey, D., Kerrigan, S., Schenone, A., Fabbri, S., Valsecchi, M.G., Mazzeo, A., Pace, A., Pessino, A., Schenone, A., Toscano, A., Argyriou, A.A., Brouwer, B., Frigeni, B., Piras, B., Briani, C., Dalla Torre, C., Dominguez Gonzalez, C., Faber, C.G., Tomasello, C., Binda, D., Brandsma, D., Cortinovis, D., Psimaras, D., Ricard, D., Storey, D., Cornblath, D.R., Galiè, E., Lindeck Pozza, E., Rossi, E., Vanhoutte, E.K., Lanzani, F., Pastorelli, F., Altavilla, G., Cavaletti, G., Granata, G., Kalofonos, H.P., Ghignotti, I., Merkies, I.S.J., Bruna, J., Hense, J., Heimans, J.J., Mattavelli, L., Padua, L., Reni, L., Bakkers, M., Boogerd, M., Campagnolo, M., Cazzaniga, M., Eurelings, M., Leandri, M., Lucchetta, M., Penas Prado, M., Russo, M., Valsecchi, M.G., Piatti, M.L., Alberti, P., Bidoli, P., Grant, R., Plasmati, R., Velasco, R., Lalisang, R.I., Meijer, R.J., Fabbri, S., Dorsey, S.G., Galimberti, S., Kerrigan, S., Koeppen, S., Postma, T.J., Boogerd, W., Grisold, W.

“…Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication of cancer treatment. Thus far, the impact of CIPN has not…”
Get full text

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer by A. Gandini, V. Martelli, L. Belgioia, S. Puglisi, M. Cremante, V. Murianni, A. Damassi, C. Pirrone, F. Catalano, M. Grassi, L. Trevisan, S. Vagge, V. Andretta, S. Mammoliti, D. Comandini, G. Fornarini, A. Pessino, A. Pastorino, S. Sciallero, A. Puccini, A.F. Sobrero

“…Background: Patients with metastatic colorectal cancer (mCRC) carrying a deficit in the mismatch repair system/microsatellite instability (dMMR/MSI) show great…”
Get full text

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) by Binda, D, Vanhoutte, E.K, Cavaletti, G, Cornblath, D.R, Postma, T.J, Frigeni, B, Alberti, P, Bruna, J, Velasco, R, Argyriou, A.A, Kalofonos, H.P, Psimaras, D, Ricard, D, Pace, A, Galiè, E, Briani, C, Dalla Torre, C, Lalisang, R.I, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Storey, D, Kerrigan, S, Schenone, A, Fabbri, S, Rossi, E, Valsecchi, M.G, Faber, C.G, Merkies, I.S.J

“…Abstract Chemotherapy-induced peripheral neuropathy (CIPN) is a common neurological side-effect of cancer treatment and may lead to declines in patients’ daily…”
Get full text

First-line single-agent cetuximab in patients with advanced colorectal cancer by Pessino, A., Artale, S., Sciallero, S., Guglielmi, A., Fornarini, G., Andreotti, I.C., Mammoliti, S., Comandini, D., Caprioni, F., Bennicelli, E., Andretta, V., Siena, S., Sobrero, A.

“…Background: The anti-epidermal growth factor receptor (EGFR) antibody cetuximab is active in heavily pretreated patients with metastatic colorectal cancer…”
Get full text

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies by Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A.F., Mazzola, G., Lambiase, A., Bordignon, C.

“…asparagine-glycine-arginine-human tumour necrosis factor (NGR-hTNF), an agent selectively damaging the tumour vasculature, showed a biphasic dose–response…”
Get full text

Method for Safely Excising a Large Head and Neck Arteriovenous Malformation in the Hybrid Operating Room by Pessino, Kenneth A., Ortiz, Rafael A., Bastidas, Nicholas

“…Large head and neck arteriovenous malformations are notoriously difficult to manage given their location and propensity for extreme hemorrhage. We propose a…”
Get full text

6075 A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer by Pessino, A, Andretta, V, Guglielmi, A, Mammoliti, S, Caprioni, F, Fornarini, G, Comandini, D, Sciallero, S, Ansaldi, F, Sobrero, A

Get full text

6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens by Sobrero, A.F, Pessino, A, Andretta, V, Bennicelli, E, Fornarini, G, Caprioni, F, Comandini, D, Orsino, L, Lambiase, A, Bordignon, C

Get full text

Antisense oligodeoxynucleotide inhibition of delta protein kinase C expression accelerates induced differentiation of murine erythroleukaemia cells by Pessino, A, Passalacqua, M, Sparatore, B, Patrone, M, Melloni, E, Pontremoli, S

“…The potential regulatory role of delta protein kinase C (delta PKC) in murine erythroleukaemia cell differentiation was studied by using antisense…”
Get full text

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state by Pastorino, A., Puccini, A., Martelli, V., Grassi, M., Cremante, M., Gandini, A., Puglisi, S., Catalano, F., Murianni, V., Pessino, A., Andretta, V., Mammoliti, S., Sciallero, M.S., Comandini, D., Fornarini, G., Caprioni, F., Bregni, G., Barni, S., Labianca, R., Sobrero, A.F.

Get full text

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) by Kieffer, Jacobien M., Postma, Tjeerd J., van de Poll-Franse, Lonneke, Mols, Floortje, Heimans, Jan J., Cavaletti, Guido, Aaronson, Neil K.

“…Purpose To investigate the scale structure and psychometrics of the EORTC chemotherapy-induced peripheral neuropathy module (QLQ-CIPN20). Methods Using…”
Get full text

Repurposing chemotherapy‐induced peripheral neuropathy grading by Velasco, Roser, Argyriou, Andreas A., Cornblath, David R., Bruna, Pere, Alberti, Paola, Rossi, Emanuela, Merkies, Ingemar S. J., Psimaras, Dimitri, Briani, Chiara, Lalisang, Roy I., Schenone, Angelo, Cavaletti, Guido, Bruna, Jordi, Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Piatti, M. L., Alberti, P., Binda, D., Bidoli, P., Cazzaniga, M., Cortinovis, D., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Lucchetta, M., Campagnolo, M., Torre, C. Dalla, Faber, C. G., Merkies, I. S. J., Vanhoutte, E. K., Bakkers, M., Brouwer, B., Boogerd, M., Lalisang, R. I., Boogerd, W., Brandsma, D., Koeppen, S., Hense, J., Grant, R., Storey, D., Kerrigan, S., Schenone, A., Belllucci, M., Pessino, A., Padua, L., Granata, G., Leandri, M., Ghignotti, I., Plasmati, R., Pastorelli, F., Postma, T. J., Heimans, J. J., Eurelings, M., Meijer, R. J., Grisold, W., LindeckPozza, E., Mazzeo, A., Toscano, A., Russo, M., Tomasello, C., Altavilla, G., Penas‐Prado, M., Dominguez‐Gonzalez, C, Dorsey, S. G.

“…Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is perceived differently by patients and physicians, complicating its assessment…”
Get full text

Extracellular release of the ‘differentiation enhancing factor’, a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation by Melloni, E., Sparatore, B., Patrone, M., Pessino, A., Passalacqua, M., Pontremoli, S.

“…Differentiation enhancing factor (DEF) is a 29 kDa protein expressed in murine erythroleukemia (MEL) cells and active in promoting a significant increase in…”
Get full text

Evidence that functional erythrocyte-type glucose transporters are oligomers by PESSINO, A, HEBERT, D. N, WOON, C. W, HARRISON, S. A, CLANCY, B. M, BUXTON, J. M, CARRUTHERS, A, CZECH, M. P

“…In this study we tested the hypothesis that functional erythrocyte-type glucose transporters (GLUT1) exist as oligomeric complexes by expressing chimeric…”
Get full text

Activation of cell surface glucose transporters measured by photoaffinity labeling of insulin-sensitive 3T3-L1 adipocytes by Harrison, S A, Clancy, B M, Pessino, A, Czech, M P

“…Several studies have demonstrated that the intrinsic catalytic activity of cell surface glucose transporters is highly regulated in 3T3-L1 adipocytes…”
Get full text

Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity by Cavaletti, Guido, Cornblath, David R., Merkies, Ingemar S.J., Postma, Tjeerd J., Rossi, Emanela, Alberti, Paola, Bruna, Jordi, Argyriou, Andreas A., Briani, Chiara, Velasco, Roser, Kalofonos, Haralabos P., Psimaras, Dimitri, Ricard, Damien, Pace, Andrea, Faber, Catharina G., Lalisang, Roy I., Brandsma, Dieta, Koeppen, Susanne, Kerrigan, Simon, Schenone, Angelo, Grisold, Wolfgang, Mazzeo, Anna, Padua, Luca, Dorsey, Susan G., Penas‐Prado, Marta, Valsecchi, Maria G., Cavaletti, Guido, Cornblath, David R., Merkies, Ingemar S.J., Postma, Tjeerd J., Rossi, Emanela, Alberti, Paola, Bruna, Jordi, Argyriou, Andreas A., Briani, Chiara, Velasco, Roser, Kalofonos, Haralabos P., Psimaras, Dimitri, Ricard, Damien, Pace, Andrea, Faber, Catharina G., Lalisang, Roy I., Brandsma, Dieta, Koeppen, Susanne, Kerrigan, Simon, Schenone, Angelo, Grisold, Wolfgang, Mazzeo, Anna, Padua, Luca, Dorsey, Susan G., Penas‐Prado, Marta, Valsecchi, Maria G., Frigeni, Barbara, Lanzani, Francesca, Mattavelli, Laura, Piatti, Maria Luisa, Binda, Davide, Bidoli, Paolo, Cazzaniga, Marina, Cortinovis, Diego, Galiè, Edvina, Campagnolo, Marta, Salvalaggio, Andrea, Ruiz, Marta, Vanhoutte, Els K., Boogerd, W., Hense, J., Grant, Robin, Storey, Dawn, Reni, Lizia, Demichelis, Chiara, Pessino, Annamaria, Granata, Giuseppe, Leandri, Massimo, Ghigliotti, I., Plasmati, Rosaria, Pastorelli, Francesca, Heimans, J.J., Eurelings, Marijke, Meijer, Ron J., Pozza, Elisabeth Lindeck, Toscano, Antonio, Gentile, Luca, Santarpia, Mariacarmela, Gonzalez, C. Dominguez

“…To test if and how chemotherapy‐induced peripheral neurotoxicity (CIPN) is perceived differently by patients and physicians, making assessment and…”
Get full text

Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process by Patrone, M., Pessino, A., Passalacqua, M., Sparatore, B., Melloni, E., Pontremoli, S.

“…In addition to α, δ and ε-protein kinase C, murine erythroleukemia cells contain ζ-PKC and also a c-PKC isoform, named α 1, which shows cross-reactivity with…”
Get full text

Role of delta-PKC on the differentiation process of murine erythroleukemia cells by Sparatore, B, Pessino, A, Patrone, M, Passalacqua, M, Melloni, E, Pontremoli, S

“…In murine erythroleukemia (MEL) cells the length of the latent period before the onset of hexamethylenebisacetamide induced terminal erythroid differentiation…”
Get more information

Changes in calcium influx affect the differentiation of murine erythroleukaemia cells by Sparatore, B, Pessino, A, Patrone, M, Passalacqua, M, Melloni, E, Pontremoli, S

“…As indicated by direct evidence, obtained by altering the cell-membrane permeability for Ca2+ in murine erythroleukaemia (MEL) cells, calpain is the triggering…”
Get full text

Differential expression of protein kinase C isoform genes in three murine erythroleukemia cell variants: implication for chemical induced differentiation by Pessino, A, Sparatore, B, Patrone, M, Passalacqua, M, Melloni, E, Pontremoli, S

“…The presence of alpha, delta, epsilon, theta, and zeta protein kinase C isoforms in DS19 murine erythroleukemia cells has been established in this study. In…”
Get more information